Sherine Chan

Company: Neuroene Therapeutics

Job title: Chief Executive Officer & Co-Founder

Seminars:

Advancing Preclinical Modelling of Inherited & Rare Mitochondrial Diseases 12:00 pm

To date, animal mitochondrial DNA has remained resistant to transfection and has limited the availability of models for rare diseases. Workshop highlights include: Discover the key hurdles towards developing truly predictive models to improve translation and drug efficacy in humans Explore the newest mitochondrial transfer strategies for developing animal models to recapitulate system-wide energy crisis…Read more

day: Pre-Conference Day

Developing Brain-Penetrant Mitochondrial Protective Small Molecules for Rare Epilepsies, Mitochondrial Diseases, & Parkinson’s Disease 3:15 pm

Screening strategy that lead to the discovery of mitochondrial and neuroprotective compounds Development of mitochondrial disease models in zebrafish to understand progression of disease and as a screening toolRead more

day: Day One